Parasympathomimetic Drugs Cholinomimetics

Below is a **complete, concise-but-exhaustive medical note on *Parasympathomimetic Drugs*** following your preferred NEET-PG/MBBS/MD style. --- # **Parasympathomimetic Drugs (Cholinomimetics) – Complete Detailed Note** Parasympathomimetic drugs **mimic the actions of the parasympathetic nervous system**, primarily by **stimulating muscarinic and/or nicotinic acetylcholine receptors** or by **inhibiting acetylcholinesterase** → ↑ ACh at synapse. They are classified into **direct-acting** (act on receptors) and **indirect-acting** (AChE inhibitors). --- # **1. PHYSIOLOGY & MECHANISM** Parasympathetic activation = * **M1**: CNS, gastric glands → cognitive effects, secretion. * **M2**: Heart → ↓ HR, ↓ AV conduction. * **M3**: Smooth muscle & glands → miosis, bronchoconstriction, ↑ secretions, ↑ urination, ↑ GI motility. * **Nn**: Ganglia. * **Nm**: Neuromuscular junction. --- # **2. CLASSIFICATION** ## **A. Direct-Acting Parasympathomimetics (Muscarinic agonists)** 1. **Choline esters** * Acetylcholine * **Bethanechol** * Carbachol * Methacholine 2. **Alkaloids** * **Pilocarpine** * Muscarine * Arecoline 3. **Synthetic agonists** * Cevimeline (for Sjögren) --- ## **B. Indirect-Acting Parasympathomimetics (AChE Inhibitors)** ### **Reversible** * **Edrophonium** * **Neostigmine** * **Pyridostigmine** * **Physostigmine** * **Rivastigmine**, Donepezil, Galantamine (Alzheimer’s) ### **Irreversible (Organophosphates)** * **Echothiophate** (clinical) * **Parathion, malathion** * Novichok, VX, Sarin (toxins) --- # **3. DRUG DETAILS (MECHANISM, USES, DOSE, EFFECTS, CONTRAINDICATIONS)** --- ## **A. DIRECT ACTING** ### **1. Bethanechol** **MOA:** M3 agonist → ↑ detrusor tone, ↑ GI motility. **Uses:** * **Urinary retention** (postpartum, post-op) * **Neurogenic bladder** **Dose:** 10–50 mg PO 3–4×/day **SE:** sweating, salivation, bronchospasm, hypotension, diarrhea **Contra:** Asthma, peptic ulcer, CAD, obstruction --- ### **2. Carbachol** **MOA:** Nicotinic + muscarinic agonist **Uses:** * Glaucoma (rare now) **SE:** Severe miosis, bronchospasm --- ### **3. Pilocarpine** **MOA:** M3 agonist, ↑ secretion, miosis **Uses:** * **Acute angle-closure glaucoma** * **Chronic glaucoma** * **Sjögren syndrome** (dry mouth) **Dose:** * Ophthalmic drops: 1–4% * Oral: 5–10 mg TID **SE:** headache, brow ache, sweating **Contra:** uncontrolled asthma --- ### **4. Cevimeline** **MOA:** M3 selective agonist **Uses:** Sjögren syndrome **SE:** sweating, visual disturbance --- --- ## **B. INDIRECT ACTING – REVERSIBLE** ### **1. Edrophonium (Very short acting)** **MOA:** AChE inhibition **Uses:** * Tensilon test for MG * Differentiate MG crisis vs cholinergic crisis **SE:** bradycardia, diarrhea --- ### **2. Neostigmine** **MOA:** AChE inhibitor + some direct Nm action **Uses:** * **Myasthenia gravis** * Post-operative **ileus** * **Urinary retention** * Reversal of **non-depolarizing muscle relaxants** **Dose:** 15 mg PO every 6 hours; IV 0.04–0.07 mg/kg **SE:** salivation, diarrhea, bronchospasm **Contra:** asthma, obstruction --- ### **3. Pyridostigmine** **MOA:** AChE inhibitor **Uses:** * **Chronic MG treatment (first line)** **Dose:** 30–60 mg PO 3–6×/day **SE:** same as neostigmine --- ### **4. Physostigmine** **MOA:** Lipid soluble, crosses BBB **Uses:** * **Anticholinergic toxicity antidote** (atropine, antihistamines, TCA) **SE:** seizures (important) --- ### **5. Rivastigmine / Donepezil / Galantamine** **Uses:** * **Alzheimer’s disease** **SE:** nausea, bradycardia, syncope --- --- ## **C. INDIRECT ACTING – IRREVERSIBLE** ### **Organophosphates** **MOA:** Permanently inhibit AChE → cholinergic crisis **Effects:** DUMBBELSS * Diarrhea * Urination * Miosis * Bronchospasm * Bradycardia * Emesis * Lacrimation * Salivation * Sweating **Management:** * **Atropine** (blocks muscarinic) * **Pralidoxime (2-PAM)** before aging * Benzodiazepines for seizures --- # **4. CLINICAL EFFECTS OF PARASYMPATHOMIMETICS** ### **Eyes** * Miosis * ↑ aqueous outflow → ↓ IOP ### **Heart** * ↓ HR * ↓ AV conduction ### **Respiratory** * **Bronchoconstriction** * ↑ secretions ### **GI** * ↑ motility * ↑ secretions ### **GU** * ↑ detrusor contraction * Relax sphincters → urination ### **Glands** * Profuse sweating, lacrimation, salivation --- # **5. CONTRAINDICATIONS** * **Asthma/COPD** (bronchospasm) * **Peptic ulcer** (↑ acid) * **Coronary artery disease / hypotension** * **GI obstruction / urinary obstruction** * Parkinsonism (for some agents) * Hyperthyroidism (risk of arrhythmia) --- # **6. IMPORTANT DRUG–DRUG INTERACTIONS** * β-blockers → severe bradycardia * Anticholinergics → antagonize effect * Depolarizing relaxants (succinylcholine) → prolonged paralysis * TCA/antihistamine toxicity → physostigmine useful --- # **7. CHOLINERGIC TOXICITY (CLINICAL FEATURES)** ### **Muscarinic signs (DUMBBELSS)** * Diarrhea * Urination * Miosis * Bronchospasm * Bradycardia * Emesis * Lacrimation * Salivation * Sweating ### **Nicotinic signs** * Muscle fasciculations → paralysis * Hypertension (early) ### **CNS** * Anxiety → seizures → coma ### **Treatment** * **Atropine + Pralidoxime + Diazepam** --- # **8. HIGH-YIELD EXAM POINTS** * **Bethanechol → urinary retention** * **Pilocarpine → acute glaucoma** * **Physostigmine → antidote for atropine overdose** * **Edrophonium → MG diagnosis** * **Pyridostigmine → MG long term** * **Organophosphate poisoning → treat with atropine first** * **Cevimeline → Sjögren (M3 selective)** --- If you want, I can also generate: ✅ **20 case scenarios** ✅ **Case-based hard MCQs** ✅ **MCQ file in HTML-CSS-JS (single file as you prefer)** ✅ **Tags for SEO / NEET PG** Just tell me **“give case scenarios”** or **“give MCQs in one file”**. Below are **20 high-yield, exam-style, real-life–based case scenarios** on **Parasympathomimetic Drugs**. Each scenario includes **presentation → analysis → final diagnosis / drug logic**. --- # **20 Case Scenarios – Parasympathomimetic Drugs** --- ### **1. Postpartum urinary retention** A 26-yo woman delivered 12 hours ago and has not voided since. Bladder scan shows 780 mL urine. No obstruction. **Management:** Start **Bethanechol** to stimulate M3 → detrusor contraction → initiate urination. **Reason:** Most appropriate parasympathomimetic for urinary retention. --- ### **2. Neurogenic bladder after spinal injury** A 32-yo man with spinal cord injury passes very small amounts of urine with incomplete emptying. **Management:** **Bethanechol** for neurogenic atonic bladder. --- ### **3. Myasthenia gravis – morning fatigability** A 28-yo woman presents with ptosis worsening toward evening, improved after rest. Ice test positive. **Best chronic drug:** **Pyridostigmine** (long acting AChE inhibitor). --- ### **4. Myasthenic crisis vs cholinergic crisis** A known MG patient develops sudden respiratory weakness. You need to differentiate cause. **Test:** **Edrophonium test** (short-acting). Improvement → **Myasthenic crisis** Worsening → **Cholinergic crisis** --- ### **5. Reversal of non-depolarizing muscle relaxant** During surgery vecuronium was used. After the procedure, the patient has inadequate spontaneous breathing. **Drug to reverse:** **Neostigmine + atropine**. --- ### **6. Anticholinergic toxicity (atropine overdose)** A child accidentally ingests atropine tablets: dilated pupils, flushing, hyperthermia, tachycardia, dry mucosa, delirium. **Antidote:** **Physostigmine** (crosses BBB). --- ### **7. Acute angle-closure glaucoma attack** A 60-yo man presents with severe ocular pain, halos, fixed mid-dilated pupil, high IOP. **Immediate drug:** **Pilocarpine** to produce miosis → opens angle → ↑ drainage. --- ### **8. Sjögren syndrome – severe dry mouth** A 52-yo woman has dry mouth, dental caries, difficulty swallowing dry food. **Best drug:** **Cevimeline** or Pilocarpine (M3 agonists → ↑ salivation). --- ### **9. Alzheimer’s disease – mild cognitive decline** A 70-yo male has progressive memory loss, MMSE 22/30. **Next step:** Start **Donepezil / Rivastigmine** (central AChE inhibitors). --- ### **10. Organophosphate poisoning – farmer** A farmer exposed to pesticides presents with sweating, salivation, pinpoint pupils, vomiting, muscle fasciculations, wheezing, bradycardia. **Management:** 1. **Atropine** IV (repeat till secretions dry) 2. **Pralidoxime (2-PAM)** 3. Diazepam for seizures. --- ### **11. COPD patient mistakenly given pilocarpine** A 70-yo COPD patient develops severe bronchospasm after using a “new eye drop.” **Cause:** **Pilocarpine** can trigger bronchoconstriction → contraindicated in asthma/COPD. --- ### **12. Post-operative ileus** A 55-yo man after abdominal surgery has absent bowel sounds, abdominal distension. **Management:** **Neostigmine** (stimulates peristalsis). --- ### **13. Elderly with bradycardia after pyridostigmine** A patient on pyridostigmine for MG develops dizziness, syncope, low pulse. **Explanation:** Excessive cholinergic effect → bradycardia. **Management:** Dose reduction or add atropine if severe. --- ### **14. Nerve agent exposure in civilian** Victim in subway with pinpoint pupils, frothy secretions, apnea, seizures → suspected sarin exposure. **Management:** * High-dose **Atropine** * **Pralidoxime** ASAP * Mechanical ventilation * Diazepam --- ### **15. Glaucoma patient sees black shadows after pilocarpine** A patient complains of difficulty seeing in dark after starting pilocarpine. **Cause:** Miosis reduces night vision. --- ### **16. Child with congenital megacolon (Hirschsprung)** A child with chronic constipation is suspected to have functional obstruction. **Avoid:** **Bethanechol** because obstruction must be ruled out (risk of perforation). --- ### **17. Elderly dementia patient with bradycardia after donepezil** A 78-yo man on Donepezil for Alzheimer’s develops syncope and pulse 44 bpm. **Next step:** Stop drug → donepezil can cause **severe bradycardia**. --- ### **18. Woman with peptic ulcer – worsened symptoms** A patient with PUD is started on bethanechol for urinary retention. She develops epigastric pain. **Mechanism:** M3 activation → ↑ gastric acid secretion → worsens ulcer. **Drug contraindicated**. --- ### **19. Patient with asthma given neostigmine** A patient with bowel pseudo-obstruction is given neostigmine and develops breathlessness. **Reason:** Muscarinic agonism → bronchoconstriction. --- ### **20. Mushroom poisoning – muscarinic** A 25-yo man eats mushrooms → severe abdominal cramps, salivation, sweating, diarrhea, bradycardia. **Likely toxin:** **Muscarine** (direct muscarinic agonist). **Treatment:** **Atropine**. --- If you want, I can now generate: ✅ **20 Hard Case-Based MCQs** or ✅ **Full HTML-CSS-JS MCQ single file** or ✅ **Tags** Just tell me. Below are **20 high-yield, clinically realistic case scenarios focusing ONLY on *side-effects* of parasympathomimetic drugs**. Each case clearly shows: **drug → side-effect → mechanism → corrective action**. --- # **20 Case Scenarios – Side Effects of Parasympathomimetic Drugs** --- ### **1. Bethanechol causing severe abdominal cramps** A postpartum woman receives bethanechol for urinary retention. Within 30 minutes she develops **intense abdominal cramps + diarrhea**. **Cause:** Excessive M3 stimulation → ↑ GI motility. **Action:** Reduce dose / stop drug. --- ### **2. Bethanechol causing bronchospasm in an asthmatic** A 28-year-old asthmatic woman given bethanechol develops **wheezing and dyspnea**. **Mechanism:** M3 stimulation → bronchoconstriction. **Action:** Stop drug; give bronchodilators. --- ### **3. Pilocarpine eye drops → headache + brow ache** A glaucoma patient reports **frontal headache and brow pain** after pilocarpine drops. **Reason:** Ciliary muscle spasm. --- ### **4. Pilocarpine → excessive sweating** A patient on oral pilocarpine for Sjögren syndrome develops **profuse sweating**. **Mechanism:** M3 on sweat glands. --- ### **5. Pilocarpine → worsened night vision** A 62-yo patient reports **poor night vision** after pilocarpine. **Reason:** Miosis → reduced light entry. --- ### **6. Pilocarpine in COPD patient → acute bronchospasm** A COPD patient given pilocarpine eye drops develops **severe breathlessness**. **Mechanism:** Systemic absorption → bronchoconstriction. **Contraindicated.** --- ### **7. Neostigmine IV → bradycardia** A 40-year-old male receiving neostigmine for ileus develops **pulse 42/min**. **Reason:** Muscarinic activation of SA/AV nodes. **Action:** Give **atropine**. --- ### **8. Neostigmine → excessive salivation & diarrhea** A patient on neostigmine for MG reports **profuse salivation, watery stool**. **Mechanism:** Cholinergic excess. **Action:** Reduce dose. --- ### **9. Pyridostigmine overdose → muscle fasciculations** MG patient starts self-increasing dose and develops **muscle twitching + weakness**. **Reason:** Nicotinic receptor overactivation → depolarizing block (cholinergic crisis). --- ### **10. Pyridostigmine → severe abdominal cramps** A 32-year-old MG patient complains of **repeated abdominal cramping** after starting pyridostigmine. **Mechanism:** ↑ GI motility due to M3 stimulation. --- ### **11. Edrophonium test → worsening weakness** During Tensilon test, patient develops **more muscle weakness + vomiting**. **Interpretation:** **Cholinergic crisis** caused by edrophonium. --- ### **12. Physostigmine → seizures** A patient treated with physostigmine for atropine overdose develops **generalized seizures**. **Reason:** CNS penetration → cholinergic overactivity in brain. --- ### **13. Donepezil → syncope** An elderly Alzheimer's patient on donepezil presents with **syncope + bradycardia (HR 46)**. **Cause:** Vagal overstimulation. **Action:** Stop drug. --- ### **14. Rivastigmine patch → nausea and weight loss** A 70-year-old on rivastigmine patch reports **persistent nausea, vomiting, weight loss**. **Mechanism:** Muscarinic GI stimulation. --- ### **15. Galantamine → urinary frequency** Patient on galantamine develops **frequent urination + urgency**. **Reason:** Increased detrusor contraction (M3 effect). --- ### **16. Echothiophate (irreversible AChE inhibitor) eye drops → cataract** Long-term echothiophate use in glaucoma results in **iris pigmentation + thickened lens (cataract)**. **Mechanism:** Chronic miosis → lens changes. --- ### **17. Organophosphate exposure – pinpoint pupils** A farmer exposed to parathion has **extreme miosis → blurred vision**, interfering with work. **Mechanism:** Muscarinic overstimulation. --- ### **18. Organophosphate poisoning → bronchorrhea** A patient develops **massive airway secretions** requiring suction. **Mechanism:** M3 stimulation of glandular secretion. --- ### **19. Organophosphate toxicity → muscle paralysis** Victim develops **progressive paralysis** after initial fasciculations. **Mechanism:** Sustained nicotinic depolarization → paralysis. --- ### **20. Cevimeline → visual blurring** A 52-yo Sjögren patient on cevimeline reports **difficulty focusing and blurry near vision**. **Reason:** Ciliary muscle overcontraction (accommodation spasm). --- If you want, I can continue with: ✅ **20 HARD MCQs (side-effects only)** OR ✅ **HTML + CSS + JS MCQs in one file** OR ✅ **Tags** Just tell me.